{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:55:07Z","timestamp":1781898907664,"version":"3.54.5"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.intimp.2025.115779","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:07:15Z","timestamp":1762211235000},"page":"115779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["The emerging role of Interleukin-26 in specific autoimmune diseases: A comparative review"],"prefix":"10.1016","volume":"168","author":[{"given":"Esmaeil","family":"Yazdanpanah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloufar","family":"Orooji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Darouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepehr","family":"Dadfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh Tavassoli","family":"Razavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariush","family":"Haghmorad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.115779_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102266","article-title":"The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention","volume":"80","author":"Miller","year":"2023","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.intimp.2025.115779_bb0010","series-title":"editors. Autoimmune diseases following environmental disasters: a narrative review of the literature","author":"Mpakosi","year":"2024"},{"key":"10.1016\/j.intimp.2025.115779_bb0015","doi-asserted-by":"crossref","first-page":"1102778","DOI":"10.3389\/fimmu.2023.1102778","article-title":"T lymphocyte cell: a pivotal player in lung cancer","volume":"14","author":"Wu","year":"2023","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2025.115779_bb0020","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41581-023-00720-1","article-title":"Pathogenesis of autoimmune disease","volume":"19","author":"Pisetsky","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115779_bb0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1568-9972(03)00006-5","article-title":"The epidemiology of autoimmune diseases","volume":"2","author":"Cooper","year":"2003","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2025.115779_bb0030","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12916-024-03309-y","article-title":"Autoimmune diseases and adverse pregnancy outcomes: an umbrella review","volume":"22","author":"Singh","year":"2024","journal-title":"BMC Med."},{"issue":"5","key":"10.1016\/j.intimp.2025.115779_bb0035","article-title":"The prevalence of autoimmune disorders in women: a narrative review","volume":"12","author":"Angum","year":"2020","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.intimp.2025.115779_bb0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cell.2020.03.007","article-title":"Challenges, Progress, and prospects of developing therapies to treat autoimmune diseases","volume":"181","author":"Fugger","year":"2020","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.intimp.2025.115779_bb0045","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/eva.13167","article-title":"Why women have more autoimmune diseases than men: an evolutionary perspective","volume":"14","author":"Kronzer","year":"2021","journal-title":"Evol. Appl."},{"issue":"1","key":"10.1016\/j.intimp.2025.115779_bb0050","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s13075-019-2070-0","article-title":"Promotion of osteoclastogenesis by IL-26 in rheumatoid arthritis","volume":"21","author":"Lee","year":"2019","journal-title":"Arthritis Res. Ther."},{"issue":"4","key":"10.1016\/j.intimp.2025.115779_bb0055","doi-asserted-by":"crossref","first-page":"105","DOI":"10.21608\/ejmr.2023.191054.1331","article-title":"Role of serum IL-26 in pathogenesis of psoriasis vulgaris","volume":"4","author":"El-salam","year":"2023","journal-title":"Egyptian Journal of Medical Research"},{"issue":"4","key":"10.1016\/j.intimp.2025.115779_bb0060","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1007\/s12035-016-9846-x","article-title":"Cytokine profile in patients with progressive multiple sclerosis and its association with disease progression and disability","volume":"54","author":"Kallaur","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"7","key":"10.1016\/j.intimp.2025.115779_bb0065","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/ni.3731","article-title":"The multiple pathways to autoimmunity","volume":"18","author":"Theofilopoulos","year":"2017","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2025.115779_bb0070","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.3390\/biom14121489","article-title":"Interleukin-27 and autoimmune disorders: a compressive review of immunological functions","volume":"14","author":"Yazdanpanah","year":"2024","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.intimp.2025.115779_bb0075","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/cmi.2010.22","article-title":"The cytokine milieu in the interplay of pathogenic Th1\/Th17 cells and regulatory T cells in autoimmune disease","volume":"7","author":"Leung","year":"2010","journal-title":"Cell. Mol. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2025.115779_bb0080","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/ni.3211","article-title":"TH17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26","volume":"16","author":"Meller","year":"2015","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2025.115779_bb0085","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1089\/jir.2011.0065","article-title":"Cytokines in autoimmunity: role in induction, regulation, and treatment","volume":"31","author":"Moudgil","year":"2011","journal-title":"Journal of interferon & cytokine research\u202f: the official journal of the International Society for Interferon and Cytokine Research."},{"key":"10.1016\/j.intimp.2025.115779_bb0090","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fimmu.2019.00204","article-title":"IL-26, a cytokine with roles in extracellular DNA-induced inflammation and microbial Defense","volume":"10","author":"Larochette","year":"2019","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2025.115779_bb0095","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00109-017-1528-2","article-title":"Synovial cell production of IL-26 induces bone mineralization in spondyloarthritis","volume":"95","author":"Heftdal","year":"2017","journal-title":"J. Mol. Med."},{"issue":"5","key":"10.1016\/j.intimp.2025.115779_bb0100","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20231464","article-title":"Human neutrophils drive skin autoinflammation by releasing interleukin (IL)-26","volume":"221","author":"Baldo","year":"2024","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.intimp.2025.115779_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.797135","article-title":"Interleukin-26 expression in inflammatory bowel disease and its immunoregulatory effects on macrophages","volume":"9","author":"Song","year":"2022","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115779_bb0110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/imm.13424","article-title":"A comprehensive review of IL-26 to pave a new way for a profound understanding of the pathobiology of cancer, inflammatory diseases and infections","volume":"165","author":"Gowhari Shabgah","year":"2022","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.intimp.2025.115779_bb0115","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jid.2023.10.038","article-title":"Immunobiology of IL-26","volume":"144","author":"Gilliet","year":"2024","journal-title":"Journal of Investigative Dermatology."},{"issue":"1","key":"10.1016\/j.intimp.2025.115779_bb0120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000434646","article-title":"Interleukin-26: an emerging player in host defense and inflammation","volume":"8","author":"Tengvall","year":"2016","journal-title":"J. Innate Immun."},{"issue":"5","key":"10.1016\/j.intimp.2025.115779_bb0125","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cytogfr.2010.09.001","article-title":"Interleukin-26: an IL-10-related cytokine produced by Th17 cells","volume":"21","author":"Donnelly","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"issue":"6","key":"10.1016\/j.intimp.2025.115779_bb0130","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s41419-021-03787-5","article-title":"IL-26 mediates epidermal growth factor receptor-tyrosine kinase inhibitor resistance through endoplasmic reticulum stress signaling pathway in triple-negative breast cancer cells","volume":"12","author":"Itoh","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2025.115779_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2020.10.003","article-title":"Interleukin-26 in host defense and inflammatory disorders of the airways","volume":"57","author":"Che","year":"2021","journal-title":"Cytokine Growth Factor Rev."},{"issue":"3","key":"10.1016\/j.intimp.2025.115779_bb0140","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/17476348.2022.2045197","article-title":"IL-26 in asthma and COPD","volume":"16","author":"Cardenas","year":"2022","journal-title":"Expert Rev. Respir. Med."},{"key":"10.1016\/j.intimp.2025.115779_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188909","article-title":"Recombinant human IL-26 facilitates the innate immune response to endotoxin in the bronchoalveolar space of mice in vivo","volume":"12","author":"Bao","year":"2017","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.intimp.2025.115779_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001395","article-title":"IL-26 is overexpressed in rheumatoid arthritis and induces proinflammatory cytokine production and Th17 cell generation","volume":"10","author":"Corvaisier","year":"2012","journal-title":"PLoS Biol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115779_bb0155","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1172\/JCI99550","article-title":"IL-26 contributes to host defense against intracellular bacteria","volume":"129","author":"Dang","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.intimp.2025.115779_bb0160","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.4049\/jimmunol.172.4.2006","article-title":"Cutting edge: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2","volume":"172","author":"Sheikh","year":"2004","journal-title":"J. Immunol."},{"issue":"32","key":"10.1016\/j.intimp.2025.115779_bb0165","doi-asserted-by":"crossref","first-page":"33343","DOI":"10.1074\/jbc.M405000200","article-title":"The T-cell lymphokine interleukin-26 targets epithelial cells through the interleukin-20 receptor 1 and interleukin-10 receptor 2 chains","volume":"279","author":"H\u00f6r","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.intimp.2025.115779_bb0170","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.4049\/jimmunol.172.4.2006","article-title":"Cutting edge: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2 1","volume":"172","author":"Sheikh","year":"2004","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2025.115779_bb0175","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.3390\/jpm12101685","article-title":"IL-26 in the lung and its role in COPD inflammation","volume":"12","author":"Bartziokas","year":"2022","journal-title":"Journal of Personalized Medicine"},{"issue":"172","key":"10.1016\/j.intimp.2025.115779_bb0180","first-page":"2006","article-title":"Cutting edge: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2","volume":"2004","author":"Sheikh","year":"1950","journal-title":"Journal of immunology Baltimore, Md"},{"issue":"4","key":"10.1016\/j.intimp.2025.115779_bb0185","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jid.2018.09.037","article-title":"Biological effects of IL-26 on T cell-mediated skin inflammation, including psoriasis","volume":"139","author":"Itoh","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2025.115779_bb0190","doi-asserted-by":"crossref","first-page":"1013382","DOI":"10.3389\/fimmu.2022.1013382","article-title":"Interleukin-26-DNA complexes promote inflammation and dermal-epidermal separation in a modified human cryosection model of bullous pemphigoid","volume":"13","author":"Mizuno","year":"2022","journal-title":"Front. Immunol."},{"issue":"23","key":"10.1016\/j.intimp.2025.115779_bb0195","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.intimp.2025.115779_bb0200","doi-asserted-by":"crossref","first-page":"10922","DOI":"10.3390\/ijms222010922","article-title":"Cytokine networks in the pathogenesis of rheumatoid arthritis","volume":"22","author":"Kondo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.intimp.2025.115779_bb0205","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1002\/art.11236","article-title":"Polymorphisms in the interferon-gamma\/interleukin-26 gene region contribute to sex bias in susceptibility to rheumatoid arthritis","volume":"48","author":"Vandenbroeck","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.intimp.2025.115779_bb0210","doi-asserted-by":"crossref","first-page":"7526","DOI":"10.3390\/ijms24087526","article-title":"Interleukin 26 induces macrophage IL-9 expression in rheumatoid arthritis","volume":"24","author":"Wang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2025.115779_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040938","article-title":"Interleukin 26 skews macrophage polarization towards M1 phenotype by activating cJUN and the NF-\u03baB pathway","volume":"9","author":"Lin","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2025.115779_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102861","article-title":"Autoantibodies in systemic lupus erythematosus: from immunopathology to therapeutic target","volume":"132","author":"Lou","year":"2022","journal-title":"J. Autoimmun."},{"issue":"14","key":"10.1016\/j.intimp.2025.115779_bb0225","doi-asserted-by":"crossref","first-page":"7666","DOI":"10.3390\/ijms25147666","article-title":"Understanding autoimmunity: mechanisms, predisposing factors, and cytokine therapies","volume":"25","author":"Yasmeen","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2025.115779_bb0230","doi-asserted-by":"crossref","first-page":"24820","DOI":"10.1038\/s41598-024-76375-0","article-title":"Regional variations in serum IL-35 levels and association with systemic lupus erythematosus: a systematic review and meta-analysis","volume":"14","author":"Leerach","year":"2024","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.intimp.2025.115779_bb0235","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20240229","article-title":"Neutrophil IL-26 fuels autoinflammation","volume":"221","author":"Futosi","year":"2024","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2025.115779_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.663192","article-title":"Serum Interleukin-26 is a new biomarker for disease activity assessment in systemic lupus erythematosus","volume":"12","author":"Brilland","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115779_bb0245","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejr.2023.04.002","article-title":"Serum interleukin-26 is a promising biomarker in systemic lupus erythematosus patients: particular relation to disease activity and nephritis","volume":"45","author":"Khalil","year":"2023","journal-title":"The Egyptian Rheumatologist"},{"issue":"8 Suppl","key":"10.1016\/j.intimp.2025.115779_bb0250","first-page":"s216","article-title":"Psoriasis and psoriatic arthritis overview","volume":"22","author":"Menter","year":"2016","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.intimp.2025.115779_bb0255","article-title":"Differentiation of IL-26+ TH17 intermediates into IL-17A producers via epithelial crosstalk in psoriasis","volume":"14(1):3878","author":"Fries","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.115779_bb0260","doi-asserted-by":"crossref","first-page":"1355824","DOI":"10.3389\/fimmu.2024.1355824","article-title":"Increased interleukin-26 in the peripheral joints of patients with axial spondyloarthritis and psoriatic arthritis, co-localizing with CD68-positive synoviocytes","volume":"15","author":"Hammitzsch","year":"2024","journal-title":"Front. Immunol."},{"issue":"21","key":"10.1016\/j.intimp.2025.115779_bb0265","doi-asserted-by":"crossref","first-page":"8406","DOI":"10.3390\/ijms21218406","article-title":"Molecular and cellular mechanisms of itch in psoriasis","volume":"21","author":"Komiya","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2025.115779_bb0270","article-title":"Interleukin-26, preferentially produced by TH17 lymphocytes, regulates CNS barrier function","volume":"7","author":"Broux","year":"2020","journal-title":"Neurology: Neuroimmunology & Neuroinflammation."},{"issue":"8","key":"10.1016\/j.intimp.2025.115779_bb0275","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1080\/08820139.2019.1594247","article-title":"The effect of IL-26 on TNF-\u03b1-induced CXCL8 responses by colonic epithelial cell lines","volume":"48","author":"Weishaar","year":"2019","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.intimp.2025.115779_bb0280","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.3389\/fimmu.2020.01556","article-title":"The immune modulating properties of mucosal-associated invariant T cells","volume":"11","author":"Ioannidis","year":"2020","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2025.115779_bb0285","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1097\/MIB.0000000000000477","article-title":"Immunoregulatory pathways involved in inflammatory bowel disease","volume":"21","author":"Fonseca-Camarillo","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"issue":"9","key":"10.1016\/j.intimp.2025.115779_bb0290","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1136\/gut.2007.130112","article-title":"The role of the novel Th17 cytokine IL-26 in intestinal inflammation","volume":"58","author":"Dambacher","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.intimp.2025.115779_bb0295","doi-asserted-by":"crossref","first-page":"1055914","DOI":"10.3389\/fimmu.2022.1055914","article-title":"The role of Th17 cells in inflammatory bowel disease and the research progress","volume":"13","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2025.115779_bb0300","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1164\/rccm.201404-0689OC","article-title":"Interleukin-26 in antibacterial host defense of human lungs. Effects on neutrophil mobilization","volume":"190","author":"Che","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"30","key":"10.1016\/j.intimp.2025.115779_bb0305","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.3748\/wjg.v23.i30.5519","article-title":"Expression of Interleukin-26 is upregulated in inflammatory bowel disease","volume":"23","author":"Fujii","year":"2017","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115779_bb0310","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pharmthera.2004.11.007","article-title":"Cytokines in multiple sclerosis: from bench to bedside","volume":"106","author":"Imitola","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2025.115779_bb0315","series-title":"Pathology of multiple sclerosis: where do we stand? Continuum (Minneapolis, Minn)","volume":"19","author":"Popescu","year":"2013"},{"key":"10.1016\/j.intimp.2025.115779_bb0320","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-3-030-55035-6_6","article-title":"Immunoregulatory effects of tolerogenic probiotics in multiple sclerosis","volume":"1286","author":"Atabati","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"issue":"18","key":"10.1016\/j.intimp.2025.115779_bb0325","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.3390\/cells13181556","article-title":"The role of mesenchymal stem cells in modulating adaptive immune responses in multiple sclerosis","volume":"13","author":"Dadfar","year":"2024","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.intimp.2025.115779_bb0330","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00401-016-1631-4","article-title":"Multiple sclerosis: experimental models and reality","volume":"133","author":"Lassmann","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"7","key":"10.1016\/j.intimp.2025.115779_bb0335","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12854","article-title":"Emerging role of targeting macrophages in rheumatoid arthritis: focus on polarization, metabolism and apoptosis","volume":"53","author":"Yang","year":"2020","journal-title":"Cell Prolif."},{"issue":"16","key":"10.1016\/j.intimp.2025.115779_bb0340","doi-asserted-by":"crossref","first-page":"8946","DOI":"10.3390\/ijms22168946","article-title":"Th17-related cytokines as potential discriminatory markers between neuromyelitis optica (Devic\u2019s disease) and multiple sclerosis\u2014a review","volume":"22","author":"Maciak","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2025.115779_bb0345","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.3390\/ijms24032360","article-title":"Cytokine imbalance as a biomarker of intervertebral disk degeneration","volume":"24","author":"Shnayder","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.intimp.2025.115779_bb0350","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1111\/ajt.17178","article-title":"Humanized anti-IL-26 monoclonal antibody as a novel targeted therapy for chronic graft-versus-host disease","volume":"22","author":"Hatano","year":"2022","journal-title":"Am. J. Transplant."},{"issue":"6","key":"10.1016\/j.intimp.2025.115779_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005624","article-title":"IL-26: an emerging proinflammatory member of the IL-10 cytokine family with multifaceted actions in antiviral, antimicrobial, and autoimmune responses","volume":"12","author":"Stephen-Victor","year":"2016","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.intimp.2025.115779_bb0360","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1474-4422(23)00377-0","article-title":"Blood\u2013brain barrier dysfunction in multiple sclerosis: causes, consequences, and potential effects of therapies","volume":"23","author":"Zierfuss","year":"2024","journal-title":"The Lancet Neurology"},{"issue":"1","key":"10.1016\/j.intimp.2025.115779_bb0365","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/imm.13280","article-title":"Cytokine-regulated Th17 plasticity in human health and diseases","volume":"163","author":"Cerboni","year":"2021","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.intimp.2025.115779_bb0370","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/14728222.2022.2035720","article-title":"Novel regulators of airway epithelial barrier function during inflammation: potential targets for drug repurposing","volume":"26","author":"Sunil","year":"2022","journal-title":"Expert Opin. Ther. Targets"},{"issue":"11","key":"10.1016\/j.intimp.2025.115779_bb0375","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3390\/biomedicines9111511","article-title":"Psoriasis as an immune-mediated and inflammatory systemic disease: from pathophysiology to novel therapeutic approaches","volume":"9","author":"Campanati","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.intimp.2025.115779_bb0380","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.761317","article-title":"Complex involvement of interleukin-26 in bacterial lung infection","volume":"12","author":"Che","year":"2021","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2025.115779_bb0385","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.3390\/biomedicines11123229","article-title":"A narrative review of cytokine networks: pathophysiological and therapeutic implications for inflammatory bowel disease pathogenesis","volume":"11","author":"Vebr","year":"2023","journal-title":"Biomedicines"},{"issue":"10","key":"10.1016\/j.intimp.2025.115779_bb0390","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3390\/biology12101320","article-title":"Bone involvement in rheumatoid arthritis and spondyloartritis: an updated review","volume":"12","author":"Orsini","year":"2023","journal-title":"Biology"},{"issue":"4","key":"10.1016\/j.intimp.2025.115779_bb0395","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12946","article-title":"The TNF\/IL-23\/IL-17 axis\u2014head-to-head trials comparing different biologics in psoriasis treatment","volume":"92","author":"Ten Bergen","year":"2020","journal-title":"Scand. J. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925017679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925017679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:44:44Z","timestamp":1781898284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925017679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":79,"alternative-id":["S1567576925017679"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115779","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The emerging role of Interleukin-26 in specific autoimmune diseases: A comparative review","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115779","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115779"}}